Remove 2029 Remove Compounding Remove Packaging
article thumbnail

STAT+: Pharmalittle: We’re reading about a rare-disease drug bill, compounded Wegovy, and more

STAT

 The priority review voucher bill would almost certainly need to ride with a larger package, such as appropriations legislation, and the unanimous vote by the House Energy and Commerce Committee increases the chances of the voucher program being renewed, at least temporarily, in a government stop-gap funding bill.  Under